Gt 1 (n = 150) 34 16 27 29 Gt 2/3 (n = 78) 47 73 62 69 CD4+ Count and Efficacy of Peg-IFN alpha and RBV APRICOT: Dieterich D, et al.
{"Image DocumentName": "CD4+ Count and Efficacy of Peg-IFN alpha and RBV", "Image ImageDescription": "Q1 (2.5% to 19%) Q2 (19.1% to 25.0%) Q3 (25.0% to 32.1%) Q4 (32.1% to 69.3%) Pts With SVR (%) Gt, genotype; HCV, hepatitis C virus; IFN, interferon; RBV, ribavirin; SVR, sustained virologic response. The APRICOT study prospectively evaluated a large cohort of HIV/hepatitis C virus\u2013coinfected patients who were treated with peginterferon alfa\u20112a and ribavirin. This analysis looks at sustained virologic response according to CD4+ cell count quartile. The graph shows an apparent relationship between sustained virologic response and CD4+ cell count quartile for hepatitis C virus genotype 1 patients, meaning that patients within the lower CD4+ cell count quartiles tended to have the worst response and those in the higher count quartiles tended to do better. On the other hand, patients with genotypes 2 and 3 had good responses for all 3 CD4+ cell count quartiles. 16. Gt 1 (n = 150) Gt 2/3 (n = 78) APRICOT: Dieterich D, et al. ICAAC Abstract H Avidal, et al. JAIDS 2009.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}